http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019127781-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d4a033d4c597ad41b9ff7f3b6095053
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
filingDate 2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d22b9f8c912cfff577551b47d2202d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1073d77c12bc9a302d0c5eb2d72c778
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1647e968db8094c0d6a17a0cbd4ea6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57b8ec9d259893e25e2b3455dcb2c059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44bec444a1bb37fe11179f1c6393fb47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6009ec8fb6d4bdbbb391b392598ac664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff262cb1b3f2e4d596a15bfcf2724a5
publicationDate 2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019127781-A1
titleOfInvention Use of a microbiome profile to detect liver disease
abstract A method to detect liver fibrosis or for the differential diagnosis of non-alchohlic fatty liver disease (NAFLD) in a subject is provided. The method comprises analyzing a biological sample from a subject to determine an intestinal microbiome signature for the subject, and inspecting the intestinal microbiome signature relative to a reference intestinal microbiome signature to detect presence or absence of liver fibrosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022333163-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110751985-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110751985-B
priorityDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24180930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408914

Total number of triples: 40.